Treatment of neurogenic diabetes insipidus

Annales d'Endocrinologie

Volumn 72, Issue 6, 2011, Pages 496-499

  Chanson, Philippe ^a   Salenave, Sylvie ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; DESMOPRESSIN; MINIRINMELT; UNCLASSIFIED DRUG; VASOPRESSIN;

ANTIDIURESIS; DAILY LIFE ACTIVITY; DEHYDRATION; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG OVERDOSE; DRUG SAFETY; DRUG WITHDRAWAL; FREEZE DRYING; HEMODILUTION; HORMONE SUBSTITUTION; HUMAN; HYPONATREMIA; LOW DRUG DOSE; NEUROGENIC DIABETES INSIPIDUS; NOSE SURGERY; PATIENT EDUCATION; PATIENT MONITORING; POLYURIA; POSTOPERATIVE COMPLICATION; SHORT SURVEY; SIDE EFFECT; TABLET FORMULATION; TIME TO MAXIMUM PLASMA CONCENTRATION; TRAUMATIC BRAIN INJURY; WATER DEPRIVATION; WATER INTOXICATION;

ANTIDIURETIC AGENTS; BRAIN INJURIES; CHEMISTRY, PHARMACEUTICAL; DEAMINO ARGININE VASOPRESSIN; DIABETES INSIPIDUS, NEUROGENIC; DIAGNOSIS, DIFFERENTIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; HUMANS; INFANT;

EID: 83255185018     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2011.09.001     Document Type: Short Survey

References (21)

1. Bichet D.G. Diabètes insipides. Traité d'endocrinologie 2007, 995-1013. Flammarion Médecine-Sciences, Paris. P. Chanson, J. Young (Eds.).
2. Maghnie M., Cosi G., Genovese E., Manca-Bitti M.L., Cohen A., Zecca S., et al. Central diabetes insipidus in children and young adults. N Engl J Med 2000, 343(14):998-1007.
3. Moore K., Thompson C., Trainer P. Disorders of water balance. Clin Med 2003, 3(1):28-33.
4. Chanson P. Diabète insipide par pathologie de la tige pituitaire chez l'adulte. Ann Endocrinol (Paris) 2005, 66(1):50-54.
5. Blanco E.J., Lane A.H., Aijaz N., Blumberg D., Wilson T.A. Use of subcutaneous d-DAVP in infants with central diabetes insipidus. J Pediatr Endocrinol Metab 2006, 19(7):919-925.
6. Osterberg O., Savic R.M., Karlsson M.O., Simonsson U.S., Norgaard J.P., Walle J.V., et al. Pharmacokinetics of desmopressin administrated as an oral lyophilisate dosage form in children with primary nocturnal enuresis and healthy adults. J Clin Pharmacol 2006, 46(10):1204-1211.
7. Dossier technique Minirin Melt, Laboratoires Ferring. 2006.
8. Sheehan J.M., Sheehan J.P., Douds G.L., Page R.B. d-DAVP use in patients undergoing transsphenoidal surgery for pituitary adenomas. Acta Neurochir (Wien) 2006, 148(3):287-291. [discussion 91].
9. Kristof R.A., Rother M., Neuloh G., Klingmuller D. Incidence, clinical manifestations, and course of water and electrolyte metabolism disturbances following transsphenoidal pituitary adenoma surgery: a prospective observational study. J Neurosurg 2009, 111(3):555-562.
10. Loh J.A., Verbalis J.G. Diabetes insipidus as a complication after pituitary surgery. Nat Clin Pract Endocrinol Metab 2007, 3(6):489-494.
11. Nemergut E.C., Zuo Z., Jane J.A., Laws E.R. Predictors of diabetes insipidus after transsphenoidal surgery: a review of 881 patients. J Neurosurg 2005, 103(3):448-454.
12. Fjellestad A., Czernichow P. Central diabetes insipidus in children. V. Oral treatment with a vasopressin hormone analogue (d-DAVP). Acta Paediatr Scand 1986, 75(4):605-610.
13. Fjellestad-Paulsen A., Laborde K., Kindermans C., Czernichow P. Water-balance hormones during long-term follow-up of oral d-DAVP treatment in diabetes insipidus. Acta Paediatr 1993, 82(9):752-757.
14. Fjellestad-Paulsen A., Paulsen O., d'Agay-Abensour L., Lundin S., Czernichow P. Central diabetes insipidus: oral treatment with d-DAVP. Regul Pept 1993, 45(1-2):303-307.
15. Fjellestad-Paulsen A., Tubiana-Rufi N., Harris A., Czernichow P. Central diabetes insipidus in children. Antidiuretic effect and pharmacokinetics of intranasal and peroral 1-deamino-8-D-arginine vasopressin. Acta Endocrinol (Copenh) 1987, 115(3):307-312.
16. Fukuda I., Hizuka N., Takano K. Oral d-DAVP is a good alternative therapy for patients with central diabetes insipidus: experience of five-year treatment. Endocr J 2003, 50(4):437-443.
17. Rivkees S.A., Dunbar N., Wilson T.A. The management of central diabetes insipidus in infancy: desmopressin, low renal solute load formula, thiazide diuretics. J Pediatr Endocrinol Metab 2007, 20(4):459-469.
18. Cunnah D., Ross G., Besser G.M. Management of cranial diabetes insipidus with oral desmopressin (d-DAVP). Clin Endocrinol (Oxf) 1986, 24(3):253-257.
19. Williams T.D., Dunger D.B., Lyon C.C., Lewis R.J., Taylor F., Lightman S.L. Antidiuretic effect and pharmacokinetics of oral 1-desamino-8-D-arginine vasopressin. 1. Studies in adults and children. J Clin Endocrinol Metab 1986, 63(1):129-132.
20. Hammer M., Vilhardt H. Peroral treatment of diabetes insipidus with a polypeptide hormone analog, desmopressin. J Pharmacol Exp Ther 1985, 234(3):754-760.
21. Vande Walle J., Stockner M., Raes A., Norgaard J.P. Desmopressin 30 years in clinical use: a safety review. Curr Drug Saf 2007, 2(3):232-238.